During the past decade, JR Tokyo General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "JR Tokyo General Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "JR Tokyo General Hospital" are "Lung Diseases, Interstitial" (2 trials), "Hepatocellular Carcinoma" (1 trials), "Idiopathic Interstitial Pneumonia" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Long Coronary Artery Disease" (1 trials). Many other conditions were trialed in "JR Tokyo General Hospital" in a lesser frequency.

Most popular intervention types in "JR Tokyo General Hospital" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (3 trials), "5% Dextrose Solution" (1 trials), "Intracoronary stent implantation" (1 trials), "Placebo" (1 trials) and "TAXUS Liberté paclitaxel-eluting coronary stent system" (1 trials). Other intervention names were less common.

The vast majority of trials in "JR Tokyo General Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "JR Tokyo General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in JR Tokyo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JR Tokyo General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".